Eicosapentaenoic Acid as long-term secondary prevention after ischemic stroke
Conclusion:
Hemorrhagic stroke was not occurred in our observation of EPA prescribed patients. The clinical features of recurrent stroke patients were the existing complications of dyslipidemia and renal dysfunction.
Source: Clinical and Translational Medicine - Category: Internal Medicine Authors: Taizen NakaseMasahiro SasakiAkifumi Suzuki Source Type: research
More News: Bleeding | Cholesterol | Hemorrhagic Stroke | Internal Medicine | Ischemic Stroke | Medical Ethics | Renal Failure | Stroke | Study